D-1877-2019 Class II Terminated
FDA drug recall D-1877-2019 was initiated by Preferred Pharmaceuticals, Inc on August 29, 2019 and is designated Class II. Reason for recall: Failed Impurities/Degradation Specifications The recall status is terminated (terminated April 24, 2023). Affected quantity: 79 (90 ct.) bottles.
Recall Details
- Product Type
- Drugs
- Report Date
- October 2, 2019
- Initiation Date
- August 29, 2019
- Termination Date
- April 24, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 79 (90 ct.) bottles
Product Description
Fexofenadine HCl Tablets, 180 mg, Pkg Size 90, Mfg: Aurohealth LLC, Repackaged by Preferred Pharmaceuticals, Inc., Anaheim, CA, NDC #: 68788-6848-09
Reason for Recall
Failed Impurities/Degradation Specifications
Distribution Pattern
Product was distributed to 1 physician in Gainesville Florida.
Code Information
Lot #: G0219K, Exp 3/2021; C1419E, Exp 3/2021